Measurement of estrogen receptors in intact cells by flow cytometry

Shimin Cao, S. David Hudnall, Fortune Kohen, Leejane Lu

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background: Estrogen receptor (ER) levels in tumor cells are important for determining the outcome of treatment and the prognosis of breast cancer patients. Flow cytometry is a convenient tool for quantifying the ER in cells, but a more sensitive, reproducible method for immunostaining the ER with anti-ER antibody is needed. Materials and Methods: ER-positive human breast cancer cells MCF-7 and T47D, and ER-negative MDA-MBA-321 cells, were fixed and permeabilized by three different protocols. The cells were then stained by indirect immunofluorescence, using two commercial antibodies to ER (MA1-310 and DAKO 1D5), or by direct immunofluorescence using FITC-labeled anti-idiotypic antibody clone 1D5. The stained cells were analyzed by flow cytometry. Results: The fixation of cells with a mixture of 0.25% paraformaldehyde and 70% methanol, permeabilization with 0.05% Triton X-100, and increasing antibody and antigen reaction time led to 80-99% of cells being stained with anti-ER antibodies. The relative brightness of ER immunostaining was as follows: anti-idiotypic antibody ID5 > MA1-310 > DAKO 1D5. Conclusions: Direct immunofluorescence with the FITC-labeled anti-idiotypic antibody of permeabilized cells resulted in improved specific staining of the ER, as compared to indirect immunofluorescence with anti-ER antibodies of fixed and permeabilized cells. Increasing the length of staining, and treatment of cells with Triton X-100, are both necessary to improve the staining of intracellular antigen for flow cytometric analysis. (C) 2000 Wiley-Liss, Inc.

Original languageEnglish (US)
Pages (from-to)109-114
Number of pages6
JournalCytometry
Volume41
Issue number2
DOIs
StatePublished - 2000

Fingerprint

Estrogen Receptors
Flow Cytometry
Antibodies
Anti-Idiotypic Antibodies
Direct Fluorescent Antibody Technique
Fluorescein-5-isothiocyanate
Octoxynol
Indirect Fluorescent Antibody Technique
Staining and Labeling
Breast Neoplasms
Antigens
MCF-7 Cells
Methanol
Clone Cells

Keywords

  • Breast cancer cells
  • Estrogen receptor
  • Flow cytometry

ASJC Scopus subject areas

  • Hematology
  • Cell Biology
  • Pathology and Forensic Medicine
  • Biophysics
  • Endocrinology

Cite this

Measurement of estrogen receptors in intact cells by flow cytometry. / Cao, Shimin; David Hudnall, S.; Kohen, Fortune; Lu, Leejane.

In: Cytometry, Vol. 41, No. 2, 2000, p. 109-114.

Research output: Contribution to journalArticle

Cao, Shimin ; David Hudnall, S. ; Kohen, Fortune ; Lu, Leejane. / Measurement of estrogen receptors in intact cells by flow cytometry. In: Cytometry. 2000 ; Vol. 41, No. 2. pp. 109-114.
@article{c4e04ab4c55a4993babdeb57639a536b,
title = "Measurement of estrogen receptors in intact cells by flow cytometry",
abstract = "Background: Estrogen receptor (ER) levels in tumor cells are important for determining the outcome of treatment and the prognosis of breast cancer patients. Flow cytometry is a convenient tool for quantifying the ER in cells, but a more sensitive, reproducible method for immunostaining the ER with anti-ER antibody is needed. Materials and Methods: ER-positive human breast cancer cells MCF-7 and T47D, and ER-negative MDA-MBA-321 cells, were fixed and permeabilized by three different protocols. The cells were then stained by indirect immunofluorescence, using two commercial antibodies to ER (MA1-310 and DAKO 1D5), or by direct immunofluorescence using FITC-labeled anti-idiotypic antibody clone 1D5. The stained cells were analyzed by flow cytometry. Results: The fixation of cells with a mixture of 0.25{\%} paraformaldehyde and 70{\%} methanol, permeabilization with 0.05{\%} Triton X-100, and increasing antibody and antigen reaction time led to 80-99{\%} of cells being stained with anti-ER antibodies. The relative brightness of ER immunostaining was as follows: anti-idiotypic antibody ID5 > MA1-310 > DAKO 1D5. Conclusions: Direct immunofluorescence with the FITC-labeled anti-idiotypic antibody of permeabilized cells resulted in improved specific staining of the ER, as compared to indirect immunofluorescence with anti-ER antibodies of fixed and permeabilized cells. Increasing the length of staining, and treatment of cells with Triton X-100, are both necessary to improve the staining of intracellular antigen for flow cytometric analysis. (C) 2000 Wiley-Liss, Inc.",
keywords = "Breast cancer cells, Estrogen receptor, Flow cytometry",
author = "Shimin Cao and {David Hudnall}, S. and Fortune Kohen and Leejane Lu",
year = "2000",
doi = "10.1002/1097-0320(20001001)41:2<109::AID-CYTO5>3.0.CO;2-7",
language = "English (US)",
volume = "41",
pages = "109--114",
journal = "Communications in Clinical Cytometry",
issn = "0196-4763",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Measurement of estrogen receptors in intact cells by flow cytometry

AU - Cao, Shimin

AU - David Hudnall, S.

AU - Kohen, Fortune

AU - Lu, Leejane

PY - 2000

Y1 - 2000

N2 - Background: Estrogen receptor (ER) levels in tumor cells are important for determining the outcome of treatment and the prognosis of breast cancer patients. Flow cytometry is a convenient tool for quantifying the ER in cells, but a more sensitive, reproducible method for immunostaining the ER with anti-ER antibody is needed. Materials and Methods: ER-positive human breast cancer cells MCF-7 and T47D, and ER-negative MDA-MBA-321 cells, were fixed and permeabilized by three different protocols. The cells were then stained by indirect immunofluorescence, using two commercial antibodies to ER (MA1-310 and DAKO 1D5), or by direct immunofluorescence using FITC-labeled anti-idiotypic antibody clone 1D5. The stained cells were analyzed by flow cytometry. Results: The fixation of cells with a mixture of 0.25% paraformaldehyde and 70% methanol, permeabilization with 0.05% Triton X-100, and increasing antibody and antigen reaction time led to 80-99% of cells being stained with anti-ER antibodies. The relative brightness of ER immunostaining was as follows: anti-idiotypic antibody ID5 > MA1-310 > DAKO 1D5. Conclusions: Direct immunofluorescence with the FITC-labeled anti-idiotypic antibody of permeabilized cells resulted in improved specific staining of the ER, as compared to indirect immunofluorescence with anti-ER antibodies of fixed and permeabilized cells. Increasing the length of staining, and treatment of cells with Triton X-100, are both necessary to improve the staining of intracellular antigen for flow cytometric analysis. (C) 2000 Wiley-Liss, Inc.

AB - Background: Estrogen receptor (ER) levels in tumor cells are important for determining the outcome of treatment and the prognosis of breast cancer patients. Flow cytometry is a convenient tool for quantifying the ER in cells, but a more sensitive, reproducible method for immunostaining the ER with anti-ER antibody is needed. Materials and Methods: ER-positive human breast cancer cells MCF-7 and T47D, and ER-negative MDA-MBA-321 cells, were fixed and permeabilized by three different protocols. The cells were then stained by indirect immunofluorescence, using two commercial antibodies to ER (MA1-310 and DAKO 1D5), or by direct immunofluorescence using FITC-labeled anti-idiotypic antibody clone 1D5. The stained cells were analyzed by flow cytometry. Results: The fixation of cells with a mixture of 0.25% paraformaldehyde and 70% methanol, permeabilization with 0.05% Triton X-100, and increasing antibody and antigen reaction time led to 80-99% of cells being stained with anti-ER antibodies. The relative brightness of ER immunostaining was as follows: anti-idiotypic antibody ID5 > MA1-310 > DAKO 1D5. Conclusions: Direct immunofluorescence with the FITC-labeled anti-idiotypic antibody of permeabilized cells resulted in improved specific staining of the ER, as compared to indirect immunofluorescence with anti-ER antibodies of fixed and permeabilized cells. Increasing the length of staining, and treatment of cells with Triton X-100, are both necessary to improve the staining of intracellular antigen for flow cytometric analysis. (C) 2000 Wiley-Liss, Inc.

KW - Breast cancer cells

KW - Estrogen receptor

KW - Flow cytometry

UR - http://www.scopus.com/inward/record.url?scp=0033814083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033814083&partnerID=8YFLogxK

U2 - 10.1002/1097-0320(20001001)41:2<109::AID-CYTO5>3.0.CO;2-7

DO - 10.1002/1097-0320(20001001)41:2<109::AID-CYTO5>3.0.CO;2-7

M3 - Article

C2 - 11002266

AN - SCOPUS:0033814083

VL - 41

SP - 109

EP - 114

JO - Communications in Clinical Cytometry

JF - Communications in Clinical Cytometry

SN - 0196-4763

IS - 2

ER -